Mark Mallon
2019
Compensation breakdown
Bonus | $880,000 |
---|---|
Non-Equity Incentive Plan | $797,063 |
Option Awards | $3,804,331 |
Salary | $750,000 |
Stock Awards | $3,692,810 |
Other | $144,596 |
Total | $10,068,800 |
Mallon received $3.8M in option awards, accounting for 38% of the total pay in 2019.
Mallon also received $880K in bonus, $797.1K in non-equity incentive plan, $750K in salary, $3.7M in stock awards and $144.6K in other compensation.
Rankings
In 2019, Mark Mallon's compensation ranked 743rd out of 13,971 executives tracked by ExecPay. In other words, Mallon earned more than 94.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 743 | 95th |
Manufacturing | 262 | 95th |
Chemicals And Allied Products | 69 | 97th |
Drugs | 58 | 97th |
Pharmaceutical Preparations | 47 | 97th |
Pay ratio
Mark Mallon's Pay | $10,068,800 |
---|---|
Median Employee's Pay | $202,151 |
Pay Ratio | 50to 1 |
In 2019, the annual total compensation of Mark Mallon was $10,068,800.
The annual total compensation of the median employee at Ironwood Pharmaceuticals was $202,151.
The ratio of Mark Mallon's pay to the pay of median employee was therefore 50 to one.
Mallon's colleagues
We found five more compensation records of executives who worked with Mark Mallon at Ironwood Pharmaceuticals in 2019.
2019
Peter Hecht
Ironwood Pharmaceuticals
Chief Executive Officer
2019
Thomas McCourt
Ironwood Pharmaceuticals
President
2019
Mark Currie
Ironwood Pharmaceuticals
Chief Scientific Officer
2019
Gina Consylman
Ironwood Pharmaceuticals
Chief Financial Officer
2019
Halley Gilbert
Ironwood Pharmaceuticals